Treatment Decisions in Non-Small Cell Lung Cancer

home / scientific-interchange-and-workshop / treatment-decisions-in-non-small-cell-lung-cancer
Ticiana Leal, MD

EP. 1: Dr. Leal on the Utilization of PD-1/PD-L1 Inhibitor Monotherapy in Lung Cancer

February 21st 2022

Ticiana Leal, MD, discusses the utilization of PD-1 and PD-L1 inhibitor monotherapy in lung cancer.

Mark A. Socinski, MD

EP. 2: Dr. Socinski on Treatment Considerations for Difficult-to-Treat Patients in Lung Cancer

March 17th 2022

Mark A. Socinski, MD, executive director, Thoracic Center, medical oncologist, AdventHealth Cancer Institute, discusses therapeutic considerations for difficult-to-treat patients in lung cancer.

Edgardo S. Santos, MD, FACP

EP. 3: Dr. Santos on the Utilization of Approved Monotherapies in NSCLC

March 17th 2022

Edgardo S. Santos, MD, FACP, discusses the utilization of approved monotherapies in non–small cell lung cancer.

Treatment Decisions in Non–Small Cell Lung Cancer

EP. 4: Treatment Decisions in Non–Small Cell Lung Cancer

April 6th 2022

This publication highlights insights from expert stakeholders on the evolving therapeutic landscape of immunotherapy-based treatment regimens through a review of clinical scenarios of patients with non-small cell lung cancer.